Skip to main content
Fig. 4 | Genome Medicine

Fig. 4

From: Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy

Fig. 4

Overall survival following the presence of CH mutations in patients who underwent adjuvant therapy for stage IIB lung cancer before (A) and after PSM (B). Overall survival following the presence of CH mutations in patients who did not perform adjuvant therapy for stage IIB lung cancer before (C) and after PSM (D). CH, clonal hematopoiesis; PSM, propensity score matching; Tx, therapy

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us